Low‐density lipoprotein apheresis for recurrent focal segmental glomerulosclerosis post renal transplant in pediatric patients

• Published in: Journal of clinical apheresis 2022-08, Vol.37 (4), p.411-414
• Main Authors: Al‐mousily, Mohammad F., Nicoara, Oana, Selewski, David T., Nadig, Satish, Twombley, Katherine
• Format: Article
• Language: English
• Subjects: Apheresis; Creatinine; Kidney diseases; Kidney transplants; lipoprotein apheresis; Lipoproteins; Patients; renal transplant; steroid‐resistant nephrotic syndrome
• ISSN: 0733-2459; 1098-1101
• DOI: 10.1002/jca.21978

Low‐density lipoprotein (LDL) apheresis has been shown to improve remission in patients with steroid‐resistant nephrotic syndrome (SRNS). Here, we report a case study of two patients who failed apheresis treatment for SRNS and required transplant with subsequent recurrence of nephrotic syndrome and response to apheresis treatment. Two patients were treated with 12 sessions of LDL apheresis for SRNS without improvement and subsequently required renal transplantation. The first patient received an ABO‐incompatible kidney transplant requiring plasma exchange (PE) with subsequent recurrence of focal segmental glomerulosclerosis. The second patient also received a renal transplant after treatment failure and subsequently developed recurrence of nephrotic syndrome in the transplanted kidney. Both patients underwent repeat therapy with lipoprotein apheresis. The first patient underwent lipoprotein apheresis after completing PE with significant improvement in serum creatinine and urine protein creatinine ratio. Three years later, he continued to do well and remains in remission. The second patient also responded well to repeat therapy with lipoprotein apheresis and had significant improvement with a urine protein creatinine ratio of 0.8 and a serum creatinine of 0.9 mg/dL 6 months after transplant. Lipoprotein apheresis was able to result in remission of nephrotic syndrome in these patients with posttransplant recurrence of disease. This is the first report of patients not responding to treatment pretransplant but responding posttransplant. Lipoprotein apheresis should be considered in patients with recurrence of nephrotic syndrome after renal transplantation even with a history of treatment failure prior to transplantation.